Effict of Jaumgunbitanggami on Funtional Dizziness: A Randomized, Double-Blind, Placebo Control Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0000095

Enrollment

102

Registered

2011-02-09

Start date

2011-02-14

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : drug 1 ) Jaumgunbitanggami 8T tid pc 4weeks drug 2 ) placebo drug 8T tid pc 4weeks - starch, oil sugar

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 20year-65year 2) patients with psychogenic dizziness DHI score of 24 points 3) patients voluntarily participate in clinical trials

Exclusion criteria

Exclusion criteria: 1) The inner ear disease (Benign Paroxysmal Positional Vertigo, vestibular neuritis, acute Meniere's disease) 2) Other specific diseases (Hypoglycemia, recent stroke within 6 months, heart disease) 3) The study evaluated the effectiveness of drugs that can affect the characters are treated (Anticonvulsants, sedatives, antidepressants, sleeping pills, prostate medicine, Parkinson's drug, dimentia drug, etc.) 4) pregnant women, nursing mothers or women of childbearing age are planning to become pregnant 5) funtional dyspepsia (persistent or recurring abdominal pain or discomfor) 6) patints can not follow the physical and mental defects that if doctor determines that such 7) Other allergic diseases

Design outcomes

Primary

Measure	Time frame
Dizziness Handicap Invetory	—

Secondary

Measure	Time frame
State-Trait Anxiety Inventory-K;Beck Depression Inventory-K;UCLA Dizziness Questionnaire	—

Countries

Korea, Republic of

Contacts

Public ContactHo ryong Yoo

Daejeon Korean Medicine Hospital of Daejeon University

Outcome results